$5.2M Generic Drug Price-Fixing MDL Deal Gets Final OK

By Nadia Dreid · May 30, 2025, 10:38 PM EDT

Apotex Corp. will be paying $5.2 million to settle claims from a class of indirect purchasers alleging the drugmaker was working with other pharmaceutical companies to hike up the price of...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Decision

Case Information

Case Title

IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

Case Number

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

August 05, 2016

Recent Articles By Nadia

May 21, 2025
FTC Urges 8th Circ. Not To Pause In-House PBM Case
May 05, 2025
DC Circ. Has Doubts About Narcolepsy Drug Appeal
April 29, 2025
DC Judge Worries About 340B Rebate Program Without 'Teeth'
March 19, 2025
Anesthesiology Giant Says Private Antitrust Suit Has No Legs
March 13, 2025
Fed. Circ. Sides With Merck In Reissued Patent Debate
March 11, 2025
Hospital Orgs. Say MultiPlan Must Not Duck Price-Fix Claims
March 10, 2025
DOJ Wants In On Invisalign Monopoly Arguments At 9th Circ.
March 07, 2025
New Bellwethers Score Cert. In Generic Drug Price-Fixing MDL
February 04, 2025
Fed. Circ. Grapples With Extensions On Reissued Patents
January 31, 2025
Express Scripts Says FTC Tried To Swamp It With Lawsuits